SCHEMBL23940232

SCHEMBL23940232

CCCCCC(CCC)n1cnc2ccccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.48
HPGD P15428 1/20 0.48
KMT2A Q03164 1/20 0.48
HSD17B10 Q99714 1/20 0.48
ASAH1 Q13510 1/20 0.47
ADA P00813 1/20 0.41
SLC9A1 P19634 4/20 0.40
TDP1 Q9NUW8 1/20 0.40
DNMT3A Q9Y6K1 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
TLR8 Q9NR97 2/20 0.38
GGPS1 O95749 1/20 0.38
FDPS P14324 1/20 0.38
LMNA P02545 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
DRD2 P14416 1/20 0.37
SLC6A4 P31645 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22810522 1.00 MEN1 (0.48) MEN1HPGDKMT2AHSD17B10ASAH1
SCHEMBL26202221 0.99 ASAH1 (0.49) MEN1HPGDKMT2AHSD17B10ASAH1
SCHEMBL21559595 0.95 ASAH1 (0.51) MEN1HPGDKMT2AHSD17B10ASAH1
SCHEMBL21388677 0.95 ASAH1 (0.51) MEN1HPGDKMT2AHSD17B10ASAH1
SCHEMBL7854777 0.95 ASAH1 (0.51) MEN1HPGDKMT2AHSD17B10ASAH1
SCHEMBL22810545 0.91 MEN1 (0.48) MEN1HPGDKMT2AHSD17B10ASAH1
SCHEMBL22810547 0.87 MEN1 (0.49) MEN1HPGDKMT2AHSD17B10ASAH1
SCHEMBL11414055 0.86 MEN1 (0.51) MEN1HPGDKMT2AHSD17B10ASAH1
Bromide SCHEMBL29283499 0.85 MEN1 (0.50) MEN1HPGDKMT2AHSD17B10ASAH1
SCHEMBL4558105 0.85 ASAH1 (0.48) MEN1HPGDKMT2AHSD17B10ASAH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210323966-A1 IMIDAZOPYRIDAZINE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323966-A1 IMIDAZOPYRIDAZINE COMPOUNDS TYK2, JAK3, JAK1 MEN1 3877/4885HPGD 1814/4885KMT2A 1521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.